Eeg332 发表于 2025-3-30 12:13:29

http://reply.papertrans.cn/23/2213/221210/221210_51.png

寻找 发表于 2025-3-30 12:21:36

CD4+ T Cellsn generating anti-tumor CD4+ T cell responses have been met with limited success. However, new approaches including Chimeric Antigen Receptors (CARs) may be increase the viability of CD4+ T cells as a potential therapeutic modality in the treatment of cancer.

ostensible 发表于 2025-3-30 17:05:57

http://reply.papertrans.cn/23/2213/221210/221210_53.png

Ligneous 发表于 2025-3-30 22:23:19

http://reply.papertrans.cn/23/2213/221210/221210_54.png

免费 发表于 2025-3-31 03:08:56

http://reply.papertrans.cn/23/2213/221210/221210_55.png

我怕被刺穿 发表于 2025-3-31 05:28:46

http://reply.papertrans.cn/23/2213/221210/221210_56.png

Microgram 发表于 2025-3-31 09:57:11

http://reply.papertrans.cn/23/2213/221210/221210_57.png

技术 发表于 2025-3-31 15:53:49

http://reply.papertrans.cn/23/2213/221210/221210_58.png

kidney 发表于 2025-3-31 20:17:49

https://doi.org/10.1007/978-3-662-38531-9d on normal granulocytes (Engvall et al., Proc Natl Acad Sci U S A 75:1670–1674, 1978). As an intercellular adhesion molecule, CEA may contribute to the formation of metastasis; there is a correlation between serum CEA in patients with cancer and the incidence of hepatic metastases, but this could a

珐琅 发表于 2025-4-1 00:47:38

http://reply.papertrans.cn/23/2213/221210/221210_60.png
页: 1 2 3 4 5 [6] 7
查看完整版本: Titlebook: Cancer Therapeutic Targets; John L. Marshall Reference work 2017 Springer Science+Business Media New York 2017 Anti-angiogenic Targets.HER